Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 140 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Evaluation of combination therapy with ofatumumab and systemic corticosteroids for pemphigus: A multi-centre cohort study
Jing Mao, Siyi Bao, Ying Chen,Zheyu Zhuang, Wenyun Chen, Guomin Li, Zhili Wu,Shiling Geng, Haiqing Wang,Hui Ke,Qiuyun Xu,Niu Xiang,Ying Zou, Zhuo Liu,Lihong Chen,Xia Xiong,Bo Cheng,Ruzeng Xue,Ting Gong,Chao Ji
Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Cited0Views0WOSBibtex
0
0
A Male Infant with ALK-positive Histiocytosis Recovered Spontaneously
Zhijun Xu,Lining Huang,Ruzeng Xue
Clinical and experimental dermatologyno. 6 (2024): 620-622
Cited0Views0WOSBibtex
0
0
IL-4、IL-13在大疱性类天疱疮患者血清和疱液中的表达
ZHOU Yao, TENG Lijun, LI Guomin, XU Jie, ZHENG Jinjin, FANG Hao,XUE Ruzeng
皮肤性病诊疗学杂志（2024）
Cited0Views0Bibtex
0
0
Efficacy and Safety of Low-Dose Interleukin-2 in the Treatment of Moderate to Severe Bullous Pemphigoid: a Single Center Perspective-Controlled Trial
Ruzeng Xue, Guomin Li, Yao Zhou, Bocheng Wang,Yingping Xu, Peizhen Zhao, Lijun Teng, Jinjin Zheng,Hongfang Liu,Suyun Ji,Dirk M. Elston,Yunsheng Liang
Journal of the American Academy of Dermatology (2024)
Cited0Views0WOSBibtex
0
0
A Combination Therapy with Secukinumab and Dupilumab in Netherton Syndrome: A Prospective Pilot Study
Taoming Liu,Manman Tang, Jiao Liu, Tinghui Kong, Yuyang Tian, Sai Yang,Jiao Zhang,Suyun Ji,Zhimiao Lin,Ruzeng Xue,Yan Ding, Bin Yang,Yunsheng Liang
Journal of the American Academy of Dermatology (2024)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 142

#Citation: 378

H-Index: 13

G-Index: 17

Sociability: 6

Diversity: 3

Activity: 7

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn